About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T

Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T

NCT04707144·6 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fondation Ophtalmologique Adolphe de Rothschild

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient over 18 years old
To benefit from a medullary exploration planned by MRI 1.5T as part of a first evaluation or a re-evaluation of inflammatory involvement of the nevrax
Express consent to participate in the study
Affiliate or beneficiary of a social security scheme

You may not be if

Patient benefiting from a legal protection measure
Pregnant, parturient or breastfeeding woman
Absolute or relative contraindication to MRI

The record

StatusCompleted

PhaseNo phase

Taking part106

StartedMay 2021

UpdatedDec 13, 2023

Conditions

Multiple Sclerosis

Where6

CHU DE Bordeaux
Bordeaux, France
Chu de Clermont-Ferrand
Clermont-Ferrand, France
Chu de Lille
Lille, France